Literature DB >> 26114687

Jaw problems: Update on ARONJ.

E Kyriakidou, M Badr, S Harrison, S Atkins.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26114687     DOI： 10.1038/sj.bdj.2015.444

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


× No keyword cloud information.
  4 in total

1.  RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?

Authors:  Tim Van den Wyngaert; Kristien Wouters; Manon T Huizing; Jan B Vermorken
Journal:  Support Care Cancer       Date:  2011-01-04       Impact factor: 3.603

Review 2.  Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Oliver Ristow; Sven Otto; Matthias Troeltzsch; Bettina Hohlweg-Majert; Christoph Pautke
Journal:  J Craniomaxillofac Surg       Date:  2014-11-22       Impact factor: 2.078

Review 3.  Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents.

Authors:  Giuseppina Campisi; Stefano Fedele; Vittorio Fusco; Giuseppe Pizzo; Olga Di Fede; Alberto Bedogni
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

4.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136
  4 in total
  1 in total

Review 1.  A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.

Authors:  George Bullock; Cheryl A Miller; Alasdair McKechnie; Vanessa Hearnden
Journal:  Front Oral Health       Date:  2022-02-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.